Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
Salinomycyna–antybiotykjonoforowyoniezwykłychwłaściwościach
35
[8]SchroederG.,GierczykB.(2005)Syntetycznereceptoryjonowe–jonofory,w:G.Schroeder
(red.),Syntetycznereceptoryjonowe,Seria:ChemiaSupramolekularna,Wyd.Betagraf
PUH,Poznań.
[9]SchroederG.,ŁęskaB.,GierczykB.,EitnerK.,WojciechowskiG.,RóżalskiB.,BartlF.,
BrzezinskiB.(1999)Studiesofcomplexationofmetalcationsbytris(3,6-dioxaheptyl)-
amineinsolution,J.Mol.Struct.508,129–138.
[10]PankiewiczR.,Remlein-StarostaD.,SchroederG.,BrzezinskiB.(2006)Biological
activityandESIMSstudyofoxaalkylandhydroxyoxaalkyllasalocidesters,J.Mol.
Struct.783,136–144.
[11]AntonioR.V.,daSilvaL.P.,VercesiA.E.(1991)AlterationsinmitochondrialCa2+flux
bytheantibioticX-537A(lasalocid-A),Biochim.Biophys.ActaBioenerg.1056,250–258.
[12]HuczyńskiA.(2012)Salinomycin–ANewCancerDrugCandidate,Chem.Biol.Drug
Des.79,235–238.
[13]StryerL.(1997)Biochemia,Wyd.Nauk.PWN,Warszawa,290–292.
[14]PressmanB.C.(1976)Biologicalapplicationsofionophores,Ann.Rev.Biochem.45,
501–530.
[15]FerdaniR.,GokelG.W.(2004)Ionophores,w:J.L.Atwood,J.W.Steed(red.),Encyclo-
paediaofsupramolecularchemistry,760–766.
[16]DoblerM.(2004)NaturalCation-bindingAgents,w:G.W.Gokel(red.),Molecular
Recognition:ReceptorsforCationicGuests,267–313.
[17]StefańskaJ.,HuczyńskiA.(2008)BiologicznewłaściwościmonenzynyA,Biul.Wydz.
Farm.WUM2,12–19.
[18]MollenhauerH.H.,MorréD.J.,RoweL.D.(1990)Alterationofintracellulartrafficby
monensin:mechanism,specificityandrelationshiptotoxicity,Biochim.Biophys.Acta
1031,225–246.
[19]KevinIID.A.,MeujoD.A.F.,HamannM.T.(2009)Polyetherionophores:broad-
spectrumandpromisingbiologicallyactivemoleculesforthecontrolofdrug-resistant
bacteriaandparasites,ExpertOpin.DrugDiscov.Opt.4,109–146.
[20]MiyazakiY.,ShibuyaM.,SugawaraH.,KawaguchiO.,HirsoeC.(1974)Salinomycin,
anewpolyetherantibiotic,J.Antibiot.27,814–821.
[21]KocienskiP.J.,BrownR.C.D.,PommierA.,ProcterM.(1998)Synthesisofsalinomy-
cin,J.Chem.Soc.Perkin.Trans.1,9–39.
[22]YurkovichM.E.,TyrakisP.A.,HongH.,SunY.,SamborskyyM.,KamiyaK.,LeadlayP.F.
(2012)Alate-stageintermediateinsalinomycinbiosynthesisisrevealedbyspecific
mutationinthebiosyntheticgenecluster,Chem.Bio.Chem.13,66–71.
[23]AllenP.,BrimbleM.A.,TurnerP.(2001)PolyetherantibioticCP44,161,ActaCryst.
Sec.C57,95–96.
[24]PaulusE.F.,KurzM.,MatterH.,VertesyL.(1998)Solid-stateandsolutionstructure
ofthesalinomycin-sodiumcomplex:stabilizationofdifferentconformersforaniono-
phoreindifferentenvironments,J.Am.Chem.Soc.120,8209–8221.
[25]MitaniM.,YamanishiT.,MiyazakiY.(1975)Salinomycin:anewmonovalentcation
ionophore,Biochem.Biophys.Res.Commun.66,1231–1236.
[26]GuptaP.B.,OnderT.T.,JiangG.,TaoK.,KuperwasserC.,WeinbergR.A.,LanderE.S.
(2009)Identificationofselectiveinhibitorsofcancerstemcellsbyhigh-throughput
screening,Cell138,645–659.
[27]NaujokatC.,FuchsD.,OpelzG.(2010)Salinomycinincancer:Anewmissionforan
oldagent,Mol.Med.Rep.3,555–559.
